⌘K

Login Start Free

Home/Filings/4/0001610618-25-000102

4//SEC Filing

KARBE FRANK 4

Accession 0001610618-25-000102

CIK 0001610618other

View on SEC.gov Company Profile

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 7:41 PM ET

Size

5.0 KB

Accession

0001610618-25-000102

Insider Transaction Report

Form 4

Period: 2025-12-10

Cidara Therapeutics, Inc.CDTX

Chief Financial Officer

Transactions

Tax Payment
Common Stock
2025-12-10$219.60/sh−7,290$1,600,884→ 50,562 total

Footnotes (2)

[F1]Shares withheld for taxes on RSU vesting.
[F2]Includes 352 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on November 20, 2025.

Documents

1 file

4
wk-form4_1765586504.xmlPrimary
FORM 4

Issuer

Cidara Therapeutics, Inc.

CIK 0001610618

Entity typeother

Related Parties

1

filerCIK 0001276700

Filing Metadata

Form type: 4
Filed: Dec 11, 7:00 PM ET
Accepted: Dec 12, 7:41 PM ET
Size: 5.0 KB

View on SEC.gov